DNAJB9是纤维样肾小球肾炎的特异性免疫组化标志物
纤维样肾小球肾炎(FGN)诊断困难,本研究开发DNAJB9免疫组化并验证其诊断效能。在FGN(n=84)、淀粉样变性(n=21)、非FGN肾小球病(n=98)及健康者(n=11)肾活检中,DNAJB9染色敏感度98%、特异度>99%,免疫电镜证实其定位于FGN纤维。
要点
- DNAJB9免疫组化诊断FGN敏感度98%、特异度>99%。
- DNAJB9染色在淀粉样变性、健康者及非FGN肾病中均阴性。
- 免疫电镜显示DNAJB9定位于FGN纤维而非淀粉样纤维。
核心结论
- DNAJB9免疫组化对FGN诊断具有高敏感性和高特异性。
- 将该标志物纳入临床实践可更快速、准确诊断FGN。
研究设计与样本
- 开发DNAJB9免疫组化并在肾活检样本中测试其诊断敏感度和特异度。
- 样本包括FGN(n=84)、淀粉样变性(n=21)、非FGN肾小球病(n=98)及健康者(n=11)。
- 采用免疫电镜确定DNAJB9是否定位于FGN纤维。
主要发现
- 除2例外,所有FGN病例肾小球沉积物均呈强、均匀、模糊的DNAJB9染色。
- 2例未染色FGN病例免疫荧光仅IgG阳性(无κ或λ)。
- 淀粉样变性、健康者及非FGN肾小球病均未见DNAJB9染色,仅1例吸烟相关肾小球病有非常局灶染色。
- 免疫电镜显示DNAJB9定位于FGN纤维,而不定位于淀粉样纤维或免疫触须样肾小球病微管。
关键数值与推荐
- DNAJB9免疫组化诊断FGN的敏感度为98%,特异度>99%。
临床怎么用
- DNAJB9免疫组化可作为FGN的快速、准确诊断工具。
- 对于疑似FGN病例,可结合DNAJB9染色减少对电镜的依赖。
局限性
- 2例FGN病例DNAJB9染色阴性,且免疫荧光仅IgG阳性。
- 1例吸烟相关肾小球病出现非常局灶的DNAJB9染色。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Fibrillary glomerulonephritis (FGN) is a rare disease with unknown pathogenesis and a poor prognosis. Until now, the diagnosis of this disease has required demonstration of glomerular deposition of randomly oriented fibrils by electron microscopy that are Congo red negative and stain with antisera to Igs. We recently discovered a novel proteomic tissue biomarker for FGN, namely, DNAJB9. METHODS: In this work, we developed DNAJB9 immunohistochemistry and tested its sensitivity and specificity for the diagnosis of FGN. This testing was performed on renal biopsy samples from patients with FGN (n = 84), amyloidosis (n = 21), a wide variety of non-FGN glomerular diseases (n = 98), and healthy subjects (n = 11). We also performed immunoelectron microscopy to determine whether DNAJB9 is localized to FGN fibrils. RESULTS: Strong, homogeneous, smudgy DNAJB9 staining of glomerular deposits was seen in all but 2 cases of FGN. The 2 cases that did not stain for DNAJB9 were unique, as they had glomerular staining for IgG only (without κ or λ) on immunofluorescence. DNAJB9 staining was not observed in cases of amyloidosis, in healthy subjects, or in non-FGN glomerular diseases (with the exception of very focal staining in 1 case of smoking-related glomerulopathy), indicating 98% sensitivity and > 99% specificity. Immunoelectron microscopy showed localization of DNAJB9 to FGN fibrils but not to amyloid fibrils or immunotactoid glomerulopathy microtubules. CONCLUSION: DNAJB9 immunohistochemistry is sensitive and specific for FGN. Incorporation of this novel immunohistochemical biomarker into clinical practice will now allow more rapid and accurate diagnosis of this disease.
引用
- Nasr SH, Vrana JA, Dasari S, et al. DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis. Kidney Int Rep. 2017. PMID: 29340314. doi:10.1016/j.ekir.2017.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。